Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT07634406
Recruiting Not applicable

Nurse-Led Telehealth Frailty Management in Older Adults

NCT07634406 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-05
Last updated
2026-07-27

Condition(s) studied

Frailty

Investigational drug(s) / intervention(s)

Nurse-Led Telehealth-Supported Multicomponent Frailty Management Program

Nurse-Led Telehealth-Supported Multicomponent Frailty Management Program: The intervention is a structured 6-week multicomponent program delivered by a nurse. Following baseline assessment and individualized goal setting, participants will receive weekly telephone counseling sessions lasting approximately 20 to 25 minutes. The intervention covers frailty awareness, physical activity and mobility support, nutrition and fluid intake counseling, fall prevention and home safety, sleep and fatigue management, self-management, and healthy lifestyle behaviors. Intervention fidelity will be monitored using a standardized checklist.

Study summary

Frailty is an important geriatric syndrome associated with reduced physiological reserve, functional decline, falls, hospitalization, and increased health care use among older adults. This randomized controlled trial aims to evaluate the effect of a nurse-led telehealth-supported multicomponent frailty management program on frailty level and functional status in older adults living at home.

The study will be conducted as a single-center, two-arm, parallel-group randomized controlled trial. A total of 100 older adults aged 65 years and older who are living at home and are frail or at risk of frailty will be randomly assigned to either the intervention group or the control group in a 1:1 ratio.

Participants in the intervention group will receive an 6-week nurse-led telehealth-supported frailty management program, including weekly telephone counseling and individualized follow-up. Participants in the control group will continue usual care. Data will be collected at baseline, at 6 weeks, and at 18 weeks. The primary outcome is frailty level measured using the FRAIL Scale. Secondary outcomes include functional status, depressive symptoms, number of falls, emergency department visits, and hospitalizations.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged 65 years or older * Living at home and not receiving institutional care * Frail or at risk of frailty * Having sufficient hearing and cognitive ability to communicate by telephone * Able to read, understand, and communicate in Turkish * Providing written informed consent Exclusion Criteria: * Having advanced cognitive impairment such as dementia * Having hearing or speech problems that prevent communication * Being bedridden * Being in the terminal stage of illness * Participating in another intervention or education program at the same time * Having a serious physical or psychiatric condition that may prevent regular participation in the intervention

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Simav Doc. Dr. Ismail Karakuyu State Hospital Home Care Unit Simav Kütahya Recruiting

More Kutahya Health Sciences University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07634406 on ClinicalTrials.gov ↗ ← All trials in Turkey